Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1999 Mar;14(1):1-20.
doi: 10.1023/a:1020653312697.

Glucose loading precipitates acute encephalopathy in thiamin-deficient rats

Affiliations

Glucose loading precipitates acute encephalopathy in thiamin-deficient rats

C Zimitat et al. Metab Brain Dis. 1999 Mar.

Abstract

A rat model of glucose-precipitated Wernicke's encephalopathy (WE) has been developed in which glucose loading (10 g/kg, i.p.) of ataxic thiamin-deficient (TD) rats induced episodes of gross neurological dysfunction and sometimes death. The acute effects of a glucose load on the neurological state of thiamin-replete control and TD rats were assessed by scoring of clinical observations and performance measured on a moving belt (MB) apparatus at 30 min intervals for 2 hr after the challenge. Glucose loading or saline treatment (2.5 mL, i.p.) had no significant behavioural or clinical consequences when administered to controls or rats fed TD diet for <21 days. Glucose loading of ataxic rats fed TD diet for 28-35 days precipitated episodes of gross ataxia and signs of advanced neurological dysfunction (e.g. loss of righting reflex and hyperexcitability) leading to significant increases in the Ataxia (p<0.05) and Advanced Sign (p<0.05) scores within 2 hr after the challenge. Simultaneously, the performance of these animals on the MB decreased 10-fold. Regular glucose challenges significantly increased the rate of progression of disease in TD rats when compared with untreated TD rats. This model may be useful for the further investigation of the pathogenesis of WE at the molecular level.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Ann Neurol. 1984 Dec;16(6):673-9 - PubMed
    1. Neuron. 1996 Mar;16(3):675-86 - PubMed
    1. Clin Chim Acta. 1971 Jul;33(2):379-86 - PubMed
    1. J Neurochem. 1993 Dec;61(6):2175-82 - PubMed
    1. Experientia. 1980 Mar 15;36(3):327-8 - PubMed

Publication types

LinkOut - more resources